Literature DB >> 20525723

14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans.

R Tamisier1, J L Pépin, J Rémy, J P Baguet, J A Taylor, J W Weiss, P Lévy.   

Abstract

Obstructive sleep apnoea syndrome (OSAS) causes nocturnal chronic intermittent hypoxia (IH) that contributes to excess cardiovascular morbidity. To explore the consequences of IH, we used our recently developed model of nocturnal IH in healthy humans to characterise the profile of this blood pressure increase, to determine if it is sustained and to explore potential physiological mechanisms. We performed 24-h ambulatory monitoring of blood pressure in 12 healthy subjects before and after 2 weeks of IH exposure. We also assessed systemic haemodynamics, muscle sympathetic nerve activity (MSNA), ischaemic calf blood flow responses and baroreflex gain. We obtained blood samples for inflammatory markers before, during and after exposure. IH significantly increased daytime ambulatory blood pressure after a single night of exposure (3 mmHg for mean and diastolic) and further increased daytime pressures after 2 weeks of exposure (8 mmHg systolic and 5 mmHg diastolic). Mean ± sd MSNA increased across the exposure (17.2 ± 5.1 versus 21.7 ± 7.3 bursts·min⁻¹; p < 0.01) and baroreflex control of sympathetic outflow declined from -965.3 ± 375.1 to -598.4 ± 162.6 AIU·min⁻¹ ·mmHg⁻¹ (p < 0.01). There were no evident changes in either vascular reactivity or systemic inflammatory markers. These data are the first to show that the arterial pressure rise is sustained throughout the waking hours beyond the acute phase immediately after exposure. Moreover, they may suggest that sympathoactivation induced by IH likely contributes to blood pressure elevation and may derive from reduced baroreflex inhibition. These mechanisms may reflect those underlying the blood pressure elevation associated with OSAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20525723     DOI: 10.1183/09031936.00204209

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  84 in total

1.  CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trial.

Authors:  Monique Mendelson; Isabelle Vivodtzev; Renaud Tamisier; David Laplaud; Sonia Dias-Domingos; Jean-Philippe Baguet; Laurent Moreau; Christian Koltes; Léonidas Chavez; Gilles De Lamberterie; Frédéric Herengt; Patrick Levy; Patrice Flore; Jean-Louis Pépin
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

2.  CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.

Authors:  Malcolm Kohler; John R Stradling
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

3.  Commentary on CPAP vs. oxygen for treatment of OSA.

Authors:  Shirin Shafazand; M Safwan Badr
Journal:  J Clin Sleep Med       Date:  2014-11-15       Impact factor: 4.062

4.  Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?

Authors:  Najib T Ayas; Glen E Foster; Neomi Shah; John Floras; Ismail Laher
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

5.  Obesity: CPAP effects in sleep apnoea-what should be expected?

Authors:  Patrick Lévy; Jean-Louis Pépin
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

Review 6.  Obstructive sleep apnoea.

Authors:  Sophie D West; Chris Turnbull
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

7.  Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.

Authors:  Barbara J Morgan; Mihaela Teodorescu; David F Pegelow; Emily R Jackson; Devin L Schneider; David T Plante; James P Gapinski; Scott J Hetzel; John M Dopp
Journal:  Exp Physiol       Date:  2018-06-08       Impact factor: 2.969

Review 8.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

9.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Cerebral and Muscle Oxygenation During Intermittent Hypoxia Exposure in Healthy Humans.

Authors:  Thomas Rupp; Arthur Peyrard; Renaud Tamisier; Jean-Louis Pepin; Samuel Verges
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.